Fresenius NaturaLyte Liquid Acid Concentrate 2.0 mEq/L Potassium Too High Risk
Fresenius Medical Care recalls NaturaLyte Liquid Acid Concentrate 2.0 mEq/L (Model 08-2251-0) due to potassium concentration exceeding 2.0 mEq/L in some batches, which may cause health risks during hemodialysis.
Lower-risk recall
The label specifies the potassium concentration is 2.0 mEq/L. Some of the product in the affected lot was found to have a potassium concentration of 2.25 mEq/L.
Contact the company
What happened, in plain English
Fresenius Medical Care is recalling NaturaLyte Liquid Acid Concentrate 2.0 mEq/L (Model 08-2251-0) because some bottles had potassium levels of 2.25 mEq/L instead of the labeled 2.0 mEq/L. This could lead to health issues during hemodialysis treatments. Read more at govinfonow.com/recall/72930-fresenius-naturalyte-liquid-acid-concentrate-2-0-meq-l-potassium.
Source Summary by GovInfoNow · govinfonow.com/recall/72930-fresenius-naturalyte-liquid-acid-concentrate-2-0-meq-l-potassium · Updated September 17, 2026 · FDA enforcement record: FDA #Z-1010-2018
Cite this page
“Fresenius NaturaLyte Liquid Acid Concentrate 2.0 mEq/L Potassium Too High Risk.” GovInfoNow, updated September 17, 2026. https://govinfonow.com/recall/72930-fresenius-naturalyte-liquid-acid-concentrate-2-0-meq-l-potassium. Based on FDA recall #Z-1010-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1010-2018%22&limit=1).
Why it’s dangerous
The product is designed for use with hemodialysis machines. Higher potassium levels than labeled (2.25 mEq/L instead of 2.0 mEq/L) could cause health issues during treatment if not properly managed.
Who’s affected
Patients using hemodialysis machines with this product are most at risk. The affected product is used in specific medical treatments for kidney failure.
How to tell if you have this one
Check for the model number 08-2251-0 on the bottle. The affected lot number is 17KTAC076. This product is sold in 3.43-liter bottles.
- Brand
Fresenius Medical Care- Category
Medical device
What to do — step by step
Check Product Label
Look for the model number 08-2251-0 and lot number 17KTAC076 on the bottle.
Where it went and when
Where it was distributed
Distributed in 5 states.
FDA distribution: “US Distribution to states of: CA, FL, KS, LA, and TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: California, Florida, Kansas, Louisiana, Texas.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1010-2018 (September 29, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1010-2018 to see it in context.
- Plain-language summary written by qwen3:4b on September 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.